226 related articles for article (PubMed ID: 32765433)
1. Infections Due to Carbapenem-Resistant Bacteria in Patients With Hematologic Malignancies.
Lalaoui R; Javelle E; Bakour S; Ubeda C; Rolain JM
Front Microbiol; 2020; 11():1422. PubMed ID: 32765433
[TBL] [Abstract][Full Text] [Related]
2. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
3. A Novel Risk Predictive Scoring Model for Predicting Subsequent Infection After Carbapenem-Resistant Gram-Negative Bacteria Colonization in Hematological Malignancy Patients.
Wu Q; Qian C; Yin H; Liu F; Wu Y; Li W; Xia L; Ma L; Hong M
Front Oncol; 2022; 12():897479. PubMed ID: 35651791
[TBL] [Abstract][Full Text] [Related]
4. Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients.
Peña C; Guzmán A; Suarez C; Dominguez MA; Tubau F; Pujol M; Gudiol F; Ariza J
Antimicrob Agents Chemother; 2007 Jun; 51(6):1967-71. PubMed ID: 17420207
[TBL] [Abstract][Full Text] [Related]
5. Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria.
Cattaneo C; Di Blasi R; Skert C; Candoni A; Martino B; Di Renzo N; Delia M; Ballanti S; Marchesi F; Mancini V; Orciuolo E; Cesaro S; Prezioso L; Fanci R; Nadali G; Chierichini A; Facchini L; Picardi M; Malagola M; Orlando V; Trecarichi EM; Tumbarello M; Aversa F; Rossi G; Pagano L;
Ann Hematol; 2018 Sep; 97(9):1717-1726. PubMed ID: 29705860
[TBL] [Abstract][Full Text] [Related]
6. Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.
Yildirim I; Aytac S; Ceyhan M; Cetin M; Tuncer M; Cengiz AB; Secmeer G; Yetgin S
Pediatr Hematol Oncol; 2008 Jun; 25(4):291-9. PubMed ID: 18484473
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
[TBL] [Abstract][Full Text] [Related]
8. Febrile Neutropenia in Hematological Malignancies: Clinical and Microbiological Profile and Outcome in High Risk Patients.
Lakshmaiah KC; Malabagi AS; Govindbabu ; Shetty R; Sinha M; Jayashree RS
J Lab Physicians; 2015; 7(2):116-20. PubMed ID: 26417163
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia.
Khoo AL; Zhao YJ; Teng M; Ying D; Jin J; Chee YL; Poon LM; Lim SE; Koh LP; Chng WJ; Lim BP; Hsu LY; Chai LYA
Int J Antimicrob Agents; 2018 Sep; 52(3):350-357. PubMed ID: 29751120
[TBL] [Abstract][Full Text] [Related]
10. [Perianal swabs surveillance cultures of Carbapenem-resistant Enterobacteriaceae(CRE) can be hints for CRE bloodstream infection in patients with hematological diseases].
Xu CH; Su Y; Lyu YX; Tian ZY; Sun FJ; Lin QS; Wang C
Zhonghua Xue Ye Xue Za Zhi; 2018 Dec; 39(12):1021-1025. PubMed ID: 30612405
[No Abstract] [Full Text] [Related]
11. Clinical outcomes of children with carbapenem-resistant Acinetobacter baumannii bacteremia.
Vandepitte WP; Berge J; Andersson R
J Med Assoc Thai; 2014 Nov; 97 Suppl 11():S129-39. PubMed ID: 25509707
[TBL] [Abstract][Full Text] [Related]
12. A single-center evaluation of the risk for colonization or bacteremia with piperacillin-tazobactam- and cefepime-resistant bacteria in patients with acute leukemia receiving fluoroquinolone prophylaxis.
Nguyen AD; Heil EL; Patel NK; Duffy A; Gilmore S
J Oncol Pharm Pract; 2016 Apr; 22(2):303-7. PubMed ID: 25567517
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and mortality in bacterial bloodstream infections in patients with hematologic malignancies.
Mert D; Ceken S; Iskender G; Iskender D; Merdin A; Duygu F; Ertek M; Altuntas F
J Infect Dev Ctries; 2019 Aug; 13(8):727-735. PubMed ID: 32069257
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
Ting SW; Lee CH; Liu JW
J Microbiol Immunol Infect; 2018 Oct; 51(5):621-628. PubMed ID: 28732563
[TBL] [Abstract][Full Text] [Related]
15. Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy.
Chen CY; Tang JL; Hsueh PR; Yao M; Huang SY; Chen YC; Chen YC; Shen MC; Wang CH; Tsai W; Chang SC; Tien HF; Luh KT
J Formos Med Assoc; 2004 Jul; 103(7):526-32. PubMed ID: 15318274
[TBL] [Abstract][Full Text] [Related]
16. Gram-negative Bacteremia in Children With Hematologic Malignancies and Following Hematopoietic Stem Cell Transplantation: Epidemiology, Resistance, and Outcome.
Vinker-Shuster M; Stepensky P; Temper V; Shayovitz V; Masarwa R; Averbuch D
J Pediatr Hematol Oncol; 2019 Nov; 41(8):e493-e498. PubMed ID: 31318820
[TBL] [Abstract][Full Text] [Related]
17. Occurrence and characterization of carbapenem-resistant Gram-negative bacilli: A collaborative study of antibiotic-resistant bacteria between Indonesia and Japan.
Kuntaman K; Shigemura K; Osawa K; Kitagawa K; Sato K; Yamada N; Nishimoto K; Yamamichi F; Rahardjo D; Hadi U; Mertaniasih NM; Kinoshita S; Fujisawa M; Shirakawa T
Int J Urol; 2018 Nov; 25(11):966-972. PubMed ID: 30253445
[TBL] [Abstract][Full Text] [Related]
18. Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies.
Satlin MJ; Calfee DP; Chen L; Fauntleroy KA; Wilson SJ; Jenkins SG; Feldman EJ; Roboz GJ; Shore TB; Helfgott DC; Soave R; Kreiswirth BN; Walsh TJ
Leuk Lymphoma; 2013 Apr; 54(4):799-806. PubMed ID: 22916826
[TBL] [Abstract][Full Text] [Related]
19. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality.
Capone A; Giannella M; Fortini D; Giordano A; Meledandri M; Ballardini M; Venditti M; Bordi E; Capozzi D; Balice MP; Tarasi A; Parisi G; Lappa A; Carattoli A; Petrosillo N
Clin Microbiol Infect; 2013 Jan; 19(1):E23-E30. PubMed ID: 23137235
[TBL] [Abstract][Full Text] [Related]
20. Decrease in vancomycin-resistant Enterococcus colonization associated with a reduction in carbapenem use as empiric therapy for febrile neutropenia in patients with acute leukemia.
Ford CD; Coombs J; Stofer MG; Lopansri BK; Webb BJ; Ostronoff F; Asch J; Hoda D
Infect Control Hosp Epidemiol; 2019 Jul; 40(7):774-779. PubMed ID: 31046849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
